Latest Rheumatology News
Compounded Topical Pain Creams No Better Than Placebo
by modernClinician Editorial Team
Compounded topical pain creams are no better than placebo creams for neuropathic pain, nociceptive pain, or mixed pain, according to a study published online Feb. 5 in the Annals of Internal Medicine.
Tofacitinib Benefits Sustained for Two Years in Patients With RA
by modernClinician Editorial Team
The clinical benefits of tofacitinib in combination with methotrexate are sustained over two years among patients with rheumatoid arthritis, according to a study published online Jan. 22 in Arthritis & Rheumatology.
Longitudinal TNF Levels Mainly Stable With Adalimumab in RA
by modernClinician Editorial Team
For patients with rheumatoid arthritis, longitudinal tumor necrosis factor (TNF) concentrations are mainly stable during adalimumab treatment, although early low TNF is strongly linked to nonresponse to treatment, according to a study published in the Jan. 30 issue of Science Translational Medicine.
Pharmacist-Led Phone Follow-Up May Cut Readmission Rates
by modernClinician Editorial Team
A pharmacist-led, postdischarge structured telephone follow-up intervention can reduce 30-day and 90-day readmission rates for polypharmacy patients, according to a study published online Jan. 23 in the British Journal of Clinical Pharmacology.
Less Intraoperative Crystalloid Fluid Not Tied to Worse Surgical Outcomes
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors
Recommendations Updated for Management of Anemia in CKD
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease
Distinct Characteristics ID"d for Patients With Rheumatoid Conditions, Opioid Use Disorder